2021
DOI: 10.1055/s-0037-1610767
|View full text |Cite
|
Sign up to set email alerts
|

Recent Developments Towards Synthesis of (Het)arylbenzimidazoles

Abstract: Benzimidazole is an important heterocycle that is widely researched and utilized by the pharmaceutical industry and is one of the five most commonly used five-membered aromatic heterocyclic compounds approved by the US Food and Drug Administration. In view of their wide-ranging bioactivities, systems containing benzimidazole as one of the moieties occupy a special place among other benzimidazole derivatives. Since 2010, many improved synthetic strategies have been developed for the construction of hetaryl- and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 93 publications
(130 reference statements)
2
6
0
Order By: Relevance
“…The products were isolated after organic phases dried over Na 2 SO 4 , followed by evaporation under reduced pressure. Spectral data were in accordance with the literature [ 72 , 73 , 74 ]. See Supplementary Materials .…”
Section: Methodssupporting
confidence: 74%
“…The products were isolated after organic phases dried over Na 2 SO 4 , followed by evaporation under reduced pressure. Spectral data were in accordance with the literature [ 72 , 73 , 74 ]. See Supplementary Materials .…”
Section: Methodssupporting
confidence: 74%
“…The products were isolated after organic phases dried over Na2SO4, followed by evaporation under reduced pressure. Spectral data were in accordance with the literature [87].…”
Section: General Procedures For the Synthesis Of 1-phenyl-2-aryl(alky...supporting
confidence: 68%
“…The synthesis of three types of new regioisomeric derivatives of 2-(benzimidazol-2-yl)­quinoxaline 13 and 14 containing, in position 6 or 7, 4-methylpiperazine, 4-phenylpiperazine (Table , entries 1–5 and 6) (type I), piperidine (Table , entries 7 and 8) (type II), and morpholine (Table , entries 9 and 10) (type III) fragments, was carried out via Mamedov rearrangement by the interaction of 3-aroylquinoxalinones 9a – 9f with benzene-1,2-diamines 12a – 12d at reflux in acetic acid for 4 h. Along with the target products 13ea, 14ea (Table , entry 5) and 13ed , 14ed (Table , entry 10), byproducts 15ea , 16ea and 15ed , 16ed are formed, respectively (Figure ), as a result of nucleophilic substitution of the fluorine atom of the aryl ring with the nitrogen atom of the benzimidazole system; , mixtures of regioisomers 15ea / 16ea and 15ed / 16ed were isolated by column chromatography. The structures of compounds 13da and 14da were confirmed by the single-crystal X-ray analysis (Figure ), and the phase state of a powder mixture of these regiosomers was analyzed by powder X-ray diffraction (see Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…To check these binding interactions and antitumor activity of a novel series of regioisomeric 2-(benzimidazol-2-yl)-3-arylquinoxalines designed using a concept of molecular hybridization with the mentioned substituents in positions 6 and 7 of the benzene ring of the quinoxaline system, we studied the reactivity of 3-aroylquinoxalinones with respect to specially synthesized benzene-1,2-diamines with N -methyl, N -phenylpiperazine, piperidine, and morpholine substituents in position 4 of the benzene ring under Mamedov rearrangement conditions.…”
mentioning
confidence: 99%